Low-risk prostate lesions: An evidence review to inform discussion on losing the “cancer” label – Caitlin R. Semsarian et al.
This review found robust evidence to inform discussion of possible recalibration of diagnostic thresholds, or use of alternative labels, for low-risk prostate cancer. RCTs and cohort studies demonstrate that active surveillance is a safe option for very low-risk and low-risk prostate cancers, with extremely low [...]